12/16/2025 | Press release | Distributed by Public on 12/17/2025 08:23
Dana-Farber Cancer Institute Inc. (Dana-Farber) has agreed to pay $15,000,000 to resolve allegations that, between 2014 and 2024, it violated the False Claims Act by making materially false statements and certifications related to National Institutes of Health (NIH) research grants. Dana-Farber is a cancer treatment and research center headquartered in Boston, with locations across Massachusetts and New Hampshire. Dana-Farber receives research grant funding from federal government agencies, including NIH.